We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+7.35%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$438M
AUM Growth
+$79M
Cap. Flow
+$165M
Cap. Flow %
37.75%
Top 10 Hldgs %
55.67%
Holding
153
New
56
Increased
27
Reduced
23
Closed
42

Top Buys

Rank Stock Value
1
SMMF
Summit Financial Group, Inc.
SMMF
+$111M
2
NVS icon
Novartis
NVS
+$41.1M
3
RDHL
Redhill Biopharma
RDHL
+$23M
4
JNJ icon
Johnson & Johnson
JNJ
+$20M
5
LLY icon
Eli Lilly
LLY
+$16.7M

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$9.18M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$7.75M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$7.1M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$4.09M
5
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$3.12M

Sector Composition

Rank Sector Weight
1 Healthcare 73.63%
2 Consumer Discretionary 3%
3 Technology 2.66%
4 Industrials 1.84%
5 Consumer Staples 1.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
126
CALL
Merck
MRK
$322B
– –
-209,600
Closed -$10M
PTCT icon
127
PTC Therapeutics
PTCT
$5.68B
– –
-73,583
Closed -$1.25M
QQQ icon
128
Invesco QQQ Trust
QQQ
$453B
– –
-80,700
Closed -$7.1M
RDWR icon
129
Radware
RDWR
$1.1B
– –
-67,268
Closed -$1.21M
RIGL icon
130
Rigel Pharmaceuticals
RIGL
$681M
– –
-22,910
Closed -$653K
SEE
131
DELISTED
Sealed Air
SEE
– –
-70,000
Closed -$2.38M
SPNS
132
DELISTED
Sapiens International
SPNS
– –
-102,798
Closed -$793K
SRPT icon
133
Sarepta Therapeutics
SRPT
$1.57B
– –
-80,000
Closed -$1.63M
XOMA
134
DELISTED
Xoma
XOMA
– –
-8,000
Closed -$1.08M
TRAW icon
135
Traws Pharma
TRAW
$6.85M
– –
-2
Closed -$1.38M
INFI
136
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-100,000
Closed -$1.38M
PTLA
137
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-63,471
Closed -$1.63M
ARQL
138
DELISTED
Arqule Inc
ARQL
– –
-291,100
Closed -$626K
MDCO
139
DELISTED
Medicines Co
MDCO
– –
-44,000
Closed -$1.7M
SODA
140
PUT
DELISTED
SodaStream International Ltd
SODA
– –
-40,000
Closed -$1.99M
MACK
141
CALL
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
– –
-12,710
Closed -$533K
YHOO
142
DELISTED
Yahoo Inc
YHOO
– –
-44,138
Closed -$1.78M
BEAV
143
DELISTED
B/E Aerospace Inc
BEAV
– –
-36,873
Closed -$2.32M
PTX
144
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
– –
-5,650
Closed -$142K
XNPT
145
DELISTED
XENOPORT, INC.
XNPT
– –
-90,000
Closed -$518K
RNA
146
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
– –
-192,428
Closed -$899K
SHPG
147
DELISTED
Shire pic
SHPG
– –
-65,000
Closed -$9.18M
MDVN
148
DELISTED
MEDIVATION, INC.
MDVN
– –
-60,000
Closed -$1.92M
RPRX
149
DELISTED
Repros Therapeutics Inc.
RPRX
– –
-120,000
Closed -$2.2M
2 3 4 5
6

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q1 2014 Portfolio in Review

As of Q1 2014, Sphera Funds Management held 153 positions worth $438M, up 22% from $359M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Sphera Funds Management deployed $165M of net new capital in Q1 2014, opening 56 new positions and adding to 27 existing holdings. Its largest new stake was Summit Financial Group, Inc.: 10,921,656 shares worth $1.75M.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 43% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $4.09M trimmed.

  • Sphera Funds Management's largest Q1 2014 buy was Summit Financial Group, Inc.: 10,921,656 shares worth $1.75M.
  • Sphera Funds Management added most to Novartis in Q1 2014, an estimated $41.1M increase.
  • Sphera Funds Management's biggest Q1 2014 reduction was Teva Pharmaceuticals, cutting an estimated $4.09M.
  • Sphera Funds Management fully exited Shire pic in Q1 2014, selling an estimated $9.18M.
  • Sphera Funds Management's ten largest holdings make up 56% of its $438M portfolio in Q1 2014.
  • Sphera Funds Management opened 56 new positions and closed 42 in Q1 2014.
  • Sphera Funds Management's portfolio value rose 22% quarter-over-quarter to $438M.

Based on Sphera Funds Management's 13F filing for Q1 2014, filed 14 May 2014.